Maria Luigia Carbone

7PUBLICATIONS
11CO-AUTHORS
Molecular targetsNanoscale characterisationMicrofluidics and nanofluidicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 14, 2026
Immune-Related Adverse Events in Patients with Melanoma Treated with B-RAF/MEK Target Therapy: Occurrence and Circulating Immune Cell Analysis.

Alessia Capone, Maria Luigia Carbone, Simona Mastroeni

|Feb 25, 2025
Tattoo Ink Metal Nanoparticles: Assessment of Toxicity In Vitro and with a Novel Human Ex Vivo Model.

Beatrice Battistini, Daniela Lulli, Beatrice Bocca

|Jan 25, 2025
Vascular Endothelial Growth Factor (VEGF) Family and the Immune System: Activators or Inhibitors?

Cristina Maria Failla, Maria Luigia Carbone, Carmela Ramondino

|Oct 16, 2024
Survival of Patients with Metastatic Melanoma Treated with Ipilimumab after PD-1 Inhibitors: A Single-Center Real-World Study.

Sofia Verkhovskaia, Rosa Falcone, Francesca Romana Di Pietro

|Dec 24, 2021
Reduced Interleukin-17-Expressing Cells in Cutaneous Melanoma.

Anna Tosi, Lavinia Nardinocchi, Maria Luigia Carbone

|Jul 02, 2021
Merkel Cell Carcinoma.

Elena Dellambra, Maria Luigia Carbone, Francesca Ricci

Pageof 2

Frequent Collaborators

7 joint publications

Cristina Maria Failla

2 joint publications

Elena Dellambra

2 joint publications

Francesca Romana Di Pietro

1 joint publications

Damiano Abeni